商业事件2026-10-24 18:08
手握10亿资金，分红不手软，百普赛斯为何执意二闯港交所？
手握10亿资金，分红不手软，百普赛斯为何执意二闯港交所？
重金押注瑞士为哪般？
重金押注瑞士为哪般？
商业观察钛媒体
TOCANVC / BUSINESS
商业事件
持续追踪国内外重要财经与资本事件。
商业事件2026-10-19 16:52
Switzerland’s Nouscom bags €120 million to bring innovative cancer immunotherapy closer to clinical trials
Switzerland’s Nouscom bags €120 million to bring innovative cancer immunotherapy closer to clinical trials
Basel-based Nouscom, a clinical-stage, cancer interception focused BioTech developing next-generation immunotherapies, today announced the closing of an oversubscribed €120 million ($135 million) Series D financing to fund the advancement of an investigational off-the-shelf neoantigen-based cancer immunotherapy. The round was co-led by M Ventures and Revelation Partners alongside new investors Angelini Ventures, the EIB, and Neva […] The post Switzerland’s Nouscom bags €120 million to bring innovative cancer immunotherapy closer to clinical trials appeared first on EU-Startups.
Basel-based Nouscom, a clinical-stage, cancer interception focused BioTech developing next-generation immunotherapies, today announced the closing of an oversubscribed €120 million ($135 million) Series D financing to fund the advancement of an investigational off-the-shelf neoantigen-based cancer immunotherapy. The round was co-led by M Ventures and Revelation Partners alongside new investors Angelini Ventures, the EIB, and Neva […] The post Switzerland’s Nouscom bags €120 million to bring innovative cancer immunotherapy closer to clinical trials appeared first on EU-Startups.
Switzerland’s NouscomEU-Startups